Related Experiment Video
Updated: Apr 11, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the
Abstract:
Cyclin-dependent kinase 2 (CDK2) is a known regulator in the cell cycle control of the G1/S and S/G2 transitions. However, the role of CDK2 in tumorigenesis is controversial. Evidence from knockout mice as well as colon cancer cell lines indicated that CDK2 is dispensable for cell proliferation. In this study, we found that ectopic CDK2 enhances Ras (G12V)-induced foci formation and knocking down CDK2 expression markedly decreases epidermal growth factor (EGF)-induced cell transformation mediated through the downregulation of c-fos expression. Interestingly, CDK2 directly phosphorylates ELK4 at Thr194 and Ser387 and regulates the ELK4 transcriptional activity, which serves as a mechanism to regulate c-fos expression. In addition, ELK4 is overexpressed in melanoma and knocking down the ELK4 or CDK2 expression significantly attenuated the malignant phenotype of melanoma cells. Taken together, our study reveals a novel function of CDK2 in EGF-induced cell transformation and the associated signal transduction pathways. This indicates that CDK2 is a useful molecular target for the chemoprevention and therapy against skin cancer.
Insights
Cyclin-dependent kinase 2 (CDK2) promotes cell transformation and c-fos expression. Targeting CDK2 and ELK4 may offer new strategies for skin cancer therapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Cyclin-dependent kinase 2 (CDK2) regulates cell cycle transitions.
- The role of CDK2 in tumorigenesis remains controversial, with some studies suggesting it is dispensable for proliferation.
Purpose of the Study:
- To investigate the novel role of CDK2 in epidermal growth factor (EGF)-induced cell transformation.
- To elucidate the underlying molecular mechanisms involving ELK4 and c-fos.
Main Methods:
- Ectopic expression and knockdown of CDK2.
- Ras (G12V)-induced foci formation assays.
- Western blotting and quantitative real-time PCR to assess protein and gene expression.
- Immunoprecipitation and in vitro kinase assays to study CDK2-ELK4 interaction.
- Analysis of ELK4 and CDK2 expression in melanoma cell lines.
Main Results:
- Ectopic CDK2 enhanced Ras-induced foci formation; CDK2 knockdown reduced EGF-induced cell transformation by downregulating c-fos.
- CDK2 directly phosphorylates ELK4, regulating its transcriptional activity and c-fos expression.
- ELK4 is overexpressed in melanoma, and knockdown of ELK4 or CDK2 attenuated melanoma cell malignancy.
Conclusions:
- CDK2 plays a novel role in EGF-induced cell transformation through the ELK4/c-fos pathway.
- CDK2 and ELK4 are potential molecular targets for skin cancer chemoprevention and therapy.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Mitogens and the Cell Cycle
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
TGF - β Signaling Pathway
Intracellular Signaling Cascades
Positive Regulator Molecules